BMRN - Biomarin Pharmaceutical Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - BMRN (1048477)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
83 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
S73-0-1-2-7

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

DM
2017-06-16
BMRNFuchs Henry JPres, Worldwide R, DS - Sale+OE$90.00-15,000136,422-10%-$1,350,000
D
2017-06-16
BMRNLawlis V BryanDirS - Sale+OE$90.00-3,75015,910-19%-$337,500
2017-06-07
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$89.61-1,00447,944-2%-$89,968
2017-06-05
BMRNDavis George EricEVP, GCS - Sale$91.04-9,47174,342-11%-$862,230
DM
2017-06-02
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.13-10,000409,725-2%-$901,300
D
2017-06-01
BMRNBienaime Jean JacquesCEOS - Sale+OE$87.53-5,000416,365-1%-$437,650
D
2017-05-31
BMRNBienaime Jean JacquesCEOS - Sale+OE$88.29-7,423416,365-2%-$655,377
D
2017-05-24
BMRNBienaime Jean JacquesCEOS - Sale+OE$88.38-5,000416,365-1%-$441,900
D
2017-05-17
BMRNBienaime Jean JacquesCEOS - Sale+OE$91.73-5,000416,365-1%-$458,650
D
2017-05-12
BMRNBienaime Jean JacquesCEOS - Sale+OE$89.23-5,000421,297-1%-$446,150
D
2017-05-08
BMRNMueller BrianSVP, Corporate ControllerS - Sale+OE$91.86-7,48213,468-36%-$687,334-1
D
2017-05-05
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale+OE$99.00-4,48651,532-8%-$444,1140
D
2017-05-05
BMRNDavis George EricEVP, GCS - Sale+OE$100.34-2,50085,251-3%-$250,8530
DM
2017-05-05
BMRNBienaime Jean JacquesCEOS - Sale+OE$96.08-10,000421,297-2%-$960,8500
2017-05-02
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$96.74-30251,532-1%-$29,215-4-8
D
2017-04-27
BMRNBienaime Jean JacquesCEOS - Sale+OE$95.72-5,000420,995-1%-$478,600-2-4
D
2017-04-25
BMRNBienaime Jean JacquesCEOS - Sale+OE$94.00-5,000420,995-1%-$470,00000
2017-03-29
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$89.15-3,89051,532-7%-$346,794-1-1+11
2017-03-16
BMRNDavis George EricEVP, GCS - Sale$91.96-2,23873,729-3%-$205,806-1-40
2017-03-16
BMRNSpiegelman Daniel KEVP, CFOS - Sale$91.96-1,98914,471-12%-$182,908-1-40
DM
2017-03-15
BMRNBienaime Jean JacquesCEOS - Sale+OE$91.69-10,000373,475-3%-$916,900-1-40
D
2017-03-13
BMRNBienaime Jean JacquesCEOS - Sale+OE$92.68-5,000389,165-1%-$463,400-2-6-4
DM
2017-03-09
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.59-11,000389,165-3%-$996,530-2-2-5
2017-03-07
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$90.56-5,00046,510-10%-$452,800+1+1-5
2017-03-06
BMRNSpiegelman Daniel KEVP, CFOS - Sale$93.32-2,30320,761-10%-$214,916+1+1-5
2017-03-06
BMRNDavis George EricEVP, GCS - Sale$93.32-1,49878,962-2%-$139,793+1+1-5
DM
2017-02-28
BMRNSpiegelman Daniel KEVP, CFOS - Sale+OE$94.07-35,00025,347-58%-$3,292,500+1-3-5
D
2017-03-01
BMRNLawlis V BryanDirS - Sale+OE$95.00-7,50013,860-35%-$712,500+1-3-5
DM
2017-01-25
BMRNBienaime Jean JacquesCEOS - Sale+OE$84.22-10,000353,483-3%-$842,200-1+2+6
DM
2017-01-10
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.58-8,000353,483-2%-$724,600+10+5
DM
2017-01-06
BMRNBienaime Jean JacquesCEOS - Sale+OE$88.49-8,000353,483-2%-$707,920-5-6+1
2017-01-09
BMRNSpiegelman Daniel KEVP, CFOS - Sale$90.00-5,00018,100-22%-$450,000-5-6+1
DM
2016-12-29
BMRNBienaime Jean JacquesCEOS - Sale+OE$83.59-8,000353,483-2%-$668,760+1+6+3
D
2016-11-25
BMRNFuchs Henry JPres, Worldwide R, DS - Sale+OE$87.40-15,000113,878-12%-$1,310,988-1-5-3
DM
2016-11-21
BMRNBienaime Jean JacquesCEOS - Sale+OE$86.62-139,487353,483-28%-$12,082,993+1-3-5
D
2016-11-18
BMRNDavis George EricEVP, GCS - Sale+OE$90.42-5,00070,798-7%-$452,100+3+10
D
2016-11-16
BMRNBienaime Jean JacquesCEOS - Sale+OE$90.97-41,670349,126-11%-$3,790,795-20-5
2016-11-09
BMRNSpiegelman Daniel KEVP, CFOS - Sale$90.61-20,00023,100-46%-$1,812,206+2-3-9
D
2016-11-09
BMRNLawlis V BryanDirS - Sale+OE$95.00-7,50013,860-35%-$712,500+2-3-9
DM
2016-11-07
BMRNBienaime Jean JacquesCEOS - Sale+OE$82.67-140,000349,126-29%-$11,574,241+2+1-10-3
DM
2016-10-27
BMRNBienaime Jean JacquesCEOS - Sale+OE$81.30-120,000349,126-26%-$9,756,438+3+2+8+19
D
2016-10-17
BMRNBienaime Jean JacquesCEOS - Sale+OE$84.39-41,666349,126-11%-$3,516,2270-4+6+7
DM
2016-10-13
BMRNBienaime Jean JacquesCEOS - Sale+OE$86.96-64,125349,126-16%-$5,576,3770-4+9+6
D
2016-09-30
BMRNBienaime Jean JacquesCEOS - Sale+OE$92.02-53,125404,342-12%-$4,888,780+1-1-12-9
D
2016-09-29
BMRNBienaime Jean JacquesCEOS - Sale+OE$93.65-53,125404,342-12%-$4,974,901+1-1-15-8
2016-09-27
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$95.61-18,46741,342-31%-$1,765,6480+3-12-4
DM
2016-09-15
BMRNBienaime Jean JacquesCEOS - Sale+OE$95.34-137,368404,342-25%-$13,096,9610-1-13-8
D
2016-08-26
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale+OE$95.06-15,000113,878-12%-$1,425,924-1+1+1-1
D
2016-08-16
BMRNBienaime Jean JacquesCEOS - Sale+OE$91.49-41,666404,342-9%-$3,811,8680+7+2-2
2016-08-01
BMRNSpiegelman Daniel KEVP, CFOS - Sale$99.33-4,00042,944-9%-$397,320+2-4-5-11
2016-08-01
BMRNDavis George EricEVP, GCS - Sale$100.00-2,16771,158-3%-$216,700+2-4-5-11
2016-08-01
BMRNMueller BrianVP, Corporate ControllerS - Sale$100.00-28714,260-2%-$28,700+2-4-5-11
D
2016-07-27
BMRNLawlis V BryanDirS - Sale+OE$95.39-1,10013,860-7%-$104,927+1+3-3-13
D
2016-07-22
BMRNLawlis V BryanDirS - Sale+OE$95.01-6,40013,860-32%-$608,064+7+9+8-8
D
2016-07-18
BMRNBienaime Jean JacquesCEOS - Sale+OE$92.72-41,666404,342-9%-$3,863,2720-20-7
2016-07-07
BMRNDavis George EricEVP, GCS - Sale$90.00-2,16770,669-3%-$195,030-1+4+11-2
2016-06-20
BMRNLawlis V BryanDirS - Sale$82.77-55013,860-4%-$45,524+1-8+15+5
D
2016-06-16
BMRNBienaime Jean JacquesCEOS - Sale+OE$80.55-41,666404,342-9%-$3,356,196-3-8+8+2
2016-06-06
BMRNSpiegelman Daniel KEVP, CFOS - Sale$89.14-1,64946,944-3%-$146,992-1-4+5-2
D
2016-05-31
BMRNSpiegelman Daniel KEVP, CFOS - Sale+OE$89.88-20,84150,394-29%-$1,873,126-2-8-16-5
D
2016-05-26
BMRNFuchs Henry JEVP, Chief Medical OfficerS - Sale+OE$87.81-15,000115,914-11%-$1,317,100-30-11-1
2016-05-23
BMRNSpiegelman Daniel KEVP, CFOS - Sale$87.07-3,76958,644-6%-$328,184+1-1-5-1
2016-05-18
BMRNBaffi RobertEVP, Technical OperationsS - Sale$87.05-5,000162,062-3%-$435,249-3+2-4+6
M
2016-05-09
BMRNDavis George EricEVP, GCS - Sale$85.11-14,65875,540-16%-$1,247,611-6-1-4-6
D
2016-05-05
BMRNBienaime Jean JacquesCEOS - Sale+OE$80.15-50,000415,914-11%-$4,007,445+4-2+2-7
2016-05-03
BMRNAjer Jeffrey RobertEVP, Chief Commercial OfficerS - Sale$86.03-41563,072-1%-$35,701-2+6+11-2
D
2016-05-02
BMRNBienaime Jean JacquesCEOS - Sale+OE$85.01-36,500421,393-8%-$3,102,931-3+3+8-5
2016-03-14
BMRNDavis George EricEVP, GCS - Sale$86.21-1,99676,190-3%-$172,079-40+6+13
2016-03-04
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfficerS - Sale$88.42-1,25546,882-3%-$110,970-30-6+8
2016-03-01
BMRNBienaime Jean JacquesCEOS - Sale$84.28-10,000366,258-3%-$842,769+2-2-6+9
2016-03-02
BMRNSpiegelman Daniel KEVP, CFOS - Sale$86.12-4,62349,688-9%-$398,120+2-2-6+9
D
2016-02-22
BMRNGrey Michael GDirS - Sale+OE$80.00-7,50026,250-22%-$600,000+1+8+10+21
2015-12-16
BMRNDavis George EricSVP, GCS - Sale$100.00-1,36266,156-2%-$136,200-1+4-22-18
2015-11-30
BMRNBienaime Jean JacquesCEOS - Sale$94.74-1,000254,5120%-$94,744-20+9-4
D
2015-11-16
BMRNLawlis V BryanDirS - Sale+OE$106.90-8,55011,850-42%-$913,998-4-9-7-21
D
2015-11-16
BMRNGrey Michael GDirS - Sale+OE$104.27-7,50026,250-22%-$782,054-4-9-7-21
D
2015-11-16
BMRNSpiegelman Daniel KEVP, CFOS - Sale+OE$104.30-20,00028,229-41%-$2,085,918-4-9-7-21
2015-11-02
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale$117.56-2635,6050%-$3,057-3-7-17-28
2015-10-15
BMRNBienaime Jean JacquesCEOS - Sale$108.24-1,000255,5120%-$108,241-1-4-4-21
2015-09-14
BMRNBienaime Jean JacquesCEOS - Sale$131.43-1,000256,5120%-$131,432+2-8-19-37
2015-08-12
BMRNBienaime Jean JacquesCEOS - Sale$134.72-1,500257,512-1%-$202,083-1-1-3-51
D
2015-07-20
BMRNAjer Jeffrey RobertSVP, Chief Commercial OfS - Sale+OE$150.00-3,00035,605-8%-$450,0000+1-6-43
2015-07-07
BMRNBienaime Jean JacquesCEOS - Sale$139.07-1,500259,012-1%-$208,600+1+4-4-29

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top